Uterine fibroids (also known as myomas) are by far the most common pelvic tumors in women of reproductive age[17]. They are benign monoclonal smooth muscle neoplasms[17]. It may cause pregnancy loss, but the link between uterine fibroids, recurrent miscarriages, and other pregnancy related complications in women is not well understood[8, 11, 12, 17]. The impact of fibroid may depend on the size and location[6, 12, 17]. It may change the shape of the intrauterine cavity, resulting in decidual atrophy or distortion of the decidua vascular architecture, affecting implantation, placentation, and the pregnancy's continuation[6, 17, 18]. Limited evidence has hampered ongoing efforts in underdeveloped nations like Ghana to address the prevalence of pregnancies and their influence on coexistence[3]. This study adopted a retrospective cross-sectional study to assess the correlation between uterine fibroid characteristics and complications in early pregnancy at RAAJ Specialist Scan.
The mean aged of pregnant women in this study was 30.72 ± 4.85years. This was comparable to the findings of Sarkodie et al.[3] who reported a mean age of 31.89 ± 7.92 years in a Ghanaian population. This finding also corroborates with another study in Cameroon which found that the majority of pregnant women were between the ages of 25 and 35[6]. Aging has been strongly linked with occurrence of fibroid[3, 6, 17]. This assertion was observed in this study, where women diagnosed of fibroid were significantly older (32.00 ± 4.47 years) than those without fibroid (30.10 ± 5.11 years). Similarly, Egbe et al.[6] also found that women with uterine fibroids in pregnancy were older than those without fibroid. On the other hand, Sarkodie et al.[3] found the highest prevalence (42.2%) of the fibroid cases among women aged < 35 years and the lowest (17.8%) recorded among women aged greater than 45 years. The difference in aged pattern between this two studies could be attributed to the type of sample investigated, accuracy of tools used and personnel involved.
The co-existence of uterine fibroids and pregnancy has been previously reported in few African studies[3, 6, 7, 19]. We reported fibroid prevalence of 31.61% among 174 pregnancy women in Cape Coast. This value is comparable to the 36.9% reported by Sarkodie et al.[3] among 244 women of childbearing age evaluated in Ghana. In a similar research of 288 pregnant women in Cameroon, the rate was twice as low (16.7%)[6]. On the contrary, a multi-center, retrospective cross-sectional survey of women in China reported a prevalence 2.63% among 112,403 women[8]. The disproportionate prevalence of fibroid in black women compared to white women has been linked to the high amounts of oestrogen receptors ER-α PP genotype present in black women[6, 20]. Also, the disparities in prevalence rates reported from these settings could be linked to the socioeconomic differences, the level of implementations of maternal and child health policy especially on early detection and treatment of maternal conditions. The relatively lower prevalence from China demonstrates that Chinese women are well protected against fibroids compared to counterparts in developing countries like Ghana and Cameroon.
The clinical presentation of uterine fibroids depends on the location of the fibroids which may be intramural, subserosal, pedunculated, submucosa or mixed[3, 6, 8, 16, 20–22]. Intramural fibroid was the predominant type identified in the current study, contributing 63.64% of all the fibroids detected. However, different patterns have been reported by previous studies. Zhao et al.[8], Cagan et al.[17], Eze et al.[19] and Egbe et al.[6] found subserosal fibroid as the most common type seen in China, Turkey, Nigeria and Cameroon respectively. Although various biological mechanisms such as genetics, microRNA, steroids, growth factors, cytokines, chemokines, and extracellular matrix components have been implicated in the development and growth of fibroids,[12, 18, 20] the disparity in fibroid locations are less studied.
Multiple fibroids were found to be much higher among women in their early pregnancy, according to the findings of this study. In this study, two-thirds of the women diagnosed with fibroid had three or more fibroids and the incident increased with age. Consistent with this finding, Eze et al.[19] found that majority of myomas co-existing with pregnancy were multiple[19]. This is contrary to previous study in China which reported a large proportion of women with single fibroid[8]. This disparity could be linked to the high levels of oestrogen receptors ER-α PP genotype in blacks compared to caucasians[6, 20]. It is also worth noting that women who have had previous fibroid surgery are less likely to be identified with numerous fibroids, a prevalent practice in Western countries like China.
The average size of fibroids in this study (5.01 ± 3.14 cm) was greater than in other studies. For instance, 2.82 ± 1.64cm reported in Cameroon by Egbe et al.[6], 3.2 ± 0.9 cm in Italy by De Vivo et al.[22] 2.16 ± 0.75cm in Turkey by Cagan et al.[17] were relatively lower compared to the current study. Although the causes of this discrepancy is unknown, disparities in socioeconomic background linked with these countries may have influenced women's reported sizes. The study samples had a variety of maternal characteristics, including but not limited to maternal age, gestational age status, parity, and so on. The majority of the women had tiny (5cm) fibroids, and the prevalence dropped as the size of the fibroids increased. This is inconsistent with findings by De Vivo et al.[22] who found a significant increase in fibroid size in a high percentage of pregnant women. On the other hand, Sarkodie et al.[3] found an evenly distributed sizes of fibroid nodules in their study population.
A number of studies have reported miscarriage, fetal death, vaginal bleeding, preterm delivery, acute abdominal and pelvic pain, placenta previa and several others as complications associated with uterine fibroids among pregnant women[6, 8, 19]. These are consistent with complications reported in this study. Vaginal bleeding was a predominant complication seen among the patients examined and this was significantly higher in patients with fibroid than those without fibroid. Similarly, Egbe et al.[6] found vaginal bleeding to be a significant complication among pregnant women with fibroid co-existence in Cameroon. Despite the report of multiple fibroids among the women, there was no significant correlation between uterine fibroids and early pregnancy complications reported in this study. On the contrary, previous study linked presence of fibroid with acute abdominal pain and vaginal bleeding[6]. An explanation for the lack of correlation found in this study could be due to the fact that a considerable number of pregnant women assessed had a small fibroid size, which fell below the threshold for an elevated risk of unfavorable obstetric outcomes[21]. Furthermore, it should be highlighted that the genesis of obstetric complications is a multifaceted process that is not solely attributed to the existence of uterine fibroids in women.
Limitation of the study
This study emphasizes the necessity of fibroids studies and supporting data on the local prevalence of fibroids in pregnancy. The strength of the study is that, large amount of data is generated and the patients are unselected, however, there was a significant amount of missing data, and unable to draw any definitive conclusions on the correlation of maternal fibroids and fetal outcomes. For example, only seven out of 55 patients diagnosed with fibroids had an echopattern captured in the reports. A prospective study will help cure this limitation.